Adagene (ADAG) Stock Highlights

2.12 | -9.01%

2024-09-19 05:37:49

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The companys platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the companys immunotherapy pipeline.

Statistics

Range Today

2.05 2.88

Volume Today 390K

Range 1 Year

1.21 4.38

Volume 1 Year 14.46M

Range 3 Year

0.9 14.98

Volume 3 Year 33.6M

Range 10 Year

0.9 31.83

Volume 10 Year 47.52M

Highlights

Market Capitalization 154.51M (small)

Floating Shares 23.16M

Current Price 2.12

Price To Earnings -4.23

Price To Revenue 111.04

Price To Book 2.73

Earnings Per Share -0.73

Payout Ratio 0%

Performance

Latest -9.01%

1 Month -15.87%

3 Months -14.17%

6 Months -26.13%

1 Year +46.21%

3 Years -85.51%

5 Years -89.61%

10 Years -89.61%

Benchmarks

Market Capitalization

242 / 368

Gross Profits

0 / 278

Total Revenue

157 / 300

Total Rank

113 / 368

Free Cashflow

0 / 352

Performance 5 years

261 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.